VANCOUVER, Oct. 23 /CNW/ - Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM)
today announced that it has filed a preliminary short form base shelf
prospectus with securities regulatory authorities in Canada and a
corresponding shelf registration statement with the United States Securities
and Exchange Commission on Form F-10.
